Dr. Mehmet Kanbay

Professor
Koc University School of Medicine, Turkiye

Highest Degree
Ph.D. in Medicine from Koc University, Turkiye

My URL
https://livedna.org/90.10988

Share this Profile

Biography

Dr. Mehmet Kanbay is currently working as Professor of Medicine and Nephrology, Koc University School of Medicine, Istanbul, Turkey. He has completed his Ph.D. in Medicine from same University. His main area of interest focuses on Biomedical Sciences. His area of expertise includes Hypertension, Uric Acid related Disorders, Mineral-Bone Disorders in Chronic Kidney Disease, Risk Factors for Cardiovascular Disease in Chronic Kidney Disease, and Inflammation in Chronic Kidney Disease. He has published 157 research articles in journals contributed as author/co-author.

Area of Interest:

Biomedical Sciences
Hypertension
Cardiovascular Disease
Chronic Kidney Disease
Inflammation

Selected Publications

  1. Zoccali, C., D. Bolignano, G. D'Arrigo, F.W. Dekker and D. Fliser et al., 2015. Validity of vascular calcification as a screening tool and as a surrogate end point in clinical research. Hypertension, 66: 3-9.
    CrossRef  |  PubMed  |  Direct Link  |  

  2. Schiller, A., M. Apetrii, M. Onofriescu, D. Siriopol and G. Veisa et al., 2015. Prognostic significance of 25-hydroxivitamin D entirely explained by a higher comorbidity burden: Experience from a South-Eastern European Dialysis Cohort. Hemodialysis Int., 19: 249-255.
    CrossRef  |  Direct Link  |  

  3. Nistor, I., I. Bararu, M.C. Apavaloaie, L. Voroneanu and M.D. Donciu et al., 2015. Vasopressin receptor antagonists for the treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials. Int. Urol. Nephrol., 47: 335-344.
    CrossRef  |  PubMed  |  Direct Link  |  

  4. Kanbay, M. and B. Afsar, 2015. Are all β-blockers the same? Nebivolol vasodilator properties and evidence for relevance in treatment of hypertension. J. Clin. Hypertens., 17: 20-21.
    CrossRef  |  PubMed  |  Direct Link  |  

  5. Elcioglu, O.C., B. Afsar, M. Takir, A.E. Toprak and A. Bakan et al., 2015. Renalase: Another puzzle piece between hypertension and simple renal cysts? Int. Urol. Nephrol., 47: 1181-1186.
    CrossRef  |  PubMed  |  Direct Link  |  

  6. Covic, A., D. Goldsmith, M.D. Donciu, D. Siriopol, R. Popa, M. Kanbay and G. London, 2015. From profusion to confusion: The saga of managing hypertension in chronic kidney disease! J. Clin. Hypertens., 17: 421-427.
    CrossRef  |  Direct Link  |  

  7. Bertelsen, N. and M. Kanbay, 2015. A new risk factor for cardiovascular disease and associated risk factors: Education. J. Clin. Hypertens., 17: 338-339.
    CrossRef  |  PubMed  |  Direct Link  |  

  8. Bakan, A., A. Oral, O.C. Elcioglu, M. Takir and O. Kostek et al., 2015. Hyperuricemia is associated with progression of IgA nephropathy. Int. Urol. Nephrol., 47: 673-678.
    CrossRef  |  PubMed  |  Direct Link  |  

  9. Aykas, F., Y. Solak, A. Erden, K. Bulut and S. Dogan et al., 2015. Persistence of cardiovascular risk factors in women with previous preeclampsia: A long-term follow-up study. J. Invest. Med., 63: 641-645.
    CrossRef  |  PubMed  |  Direct Link  |  

  10. Akin, F., O. Celik, B. Ayca, I. Altun and V.O. Diker et al., 2015. Associations of fibroblast growth factor 23 and Fetuin-A with coronary plaque burden and plaque composition in young adults. J. Invest. Med., 63: 613-619.
    CrossRef  |  PubMed  |  Direct Link  |  

  11. Afsar, B., R. Elsurer, A. Kirkpantur and M. Kanbay, 2015. Urinary sodium excretion and ambulatory blood pressure findings in patients with hypertension. J. Clin. Hypertens., 17: 200-206.
    CrossRef  |  PubMed  |  Direct Link  |  

  12. Yilmaz, M.I., Y. Solak, M. Saglam, T. Cayci and C. Acikel et al., 2014. The relationship between IL-10 levels and cardiovascular events in patients with CKD. Clin. J. Am. Soc. Nephrol., 9: 1207-1216.
    CrossRef  |  PubMed  |  Direct Link  |  

  13. Yilmaz, M.I., D. Siriopol, M. Saglam, Y.G. Kurt and H.U. Unal et al., 2014. Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease. Kidney Int., 86: 1213-1220.
    CrossRef  |  Direct Link  |  

  14. Turak, O., B. Afsar, F. Ozcan, U. Canpolat and E. Grbovic et al., 2014. Relationship between elevated morning blood pressure surge, uric acid and cardiovascular outcomes in hypertensive patients. J. Clin. Hypertens., 16: 530-535.
    CrossRef  |  Direct Link  |  

  15. Solak, Y., H. Akilli, M. Kayrak, A. Aribas and A. Gaipov et al., 2014. Uric acid level and erectile dysfunction in patients with coronary artery disease. J. Sexual Med., 11: 165-172.
    CrossRef  |  Direct Link  |  

  16. Solak, Y., A. Covic and M. Kanbay, 2014. What do we know and do not know about vitamin D?: A causal association between vitamin D receptor genetic polymorphism and hypertension. J. Clin. Hypertens., 16: 627-628.
    CrossRef  |  Direct Link  |  

  17. Ozkok, A., A. Kanbay, A.R. Odabas, A. Covic and M. Kanbay, 2014. Obstructive sleep apnea syndrome and chronic kidney disease: A new cardiorenal risk factor. Clin. Exp. Hypertens., 36: 211-216.
    CrossRef  |  Direct Link  |  

  18. Ortiz, A., A. Covic, D. Fliser, D. Fouque and D. Goldsmith et al., 2014. Epidemiology, contributors to and clinical trials of mortality risk in chronic kidney failure. Lancet, 383: 1831-1843.
    CrossRef  |  Direct Link  |  

  19. Onofriescu, M., S. Hogas, L. Voroneanu, M. Apetrii, I. Nistor, M. Kanbay and A.C. Covic, 2014. Bioimpedance-guided fluid management in maintenance hemodialysis: A pilot randomized controlled trial. Am. J. Kidney Dis., 64: 111-118.
    CrossRef  |  Direct Link  |  

  20. Kanbay, M., Y. Solak, H.U. Unal, Y.G. Kurt and M. Gok et al., 2014. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int. Urol. Nephrol., 46: 1619-1625.
    CrossRef  |  Direct Link  |  

  21. Kanbay, M., Y. Solak, A. Gaipov, M. Takir and D.E. Weiner, 2014. Allopurinol as a kidney-protective, cardioprotective and antihypertensive agent: Hype or reality? Blood Purif., 37: 172-178.
    CrossRef  |  Direct Link  |  

  22. Kanbay, M., D. Siriopol, M. Saglam, Y.G. Kurt and M. Gok et al., 2014. Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients. J. Clin. Endocrinol. Metab., 99: E1854-E1861.
    CrossRef  |  PubMed  |  Direct Link  |  

  23. Kanbay, M., D. Siriopol, I. Nistor, O.C. Elcioglu and O. Telci et al., 2014. Effects of allopurinol on endothelial dysfunction: A meta-analysis. Am. J. Nephrol., 39: 348-356.
    CrossRef  |  Direct Link  |  

  24. Kanbay, A., H. Inonu, Y. Solak, A. Erden and E. Uslu et al., 2014. Uric acid as a potential mediator of cardiovascular morbidity in obstructive sleep apnea syndrome. Eur. J. Internal Med., 25: 471-476.
    CrossRef  |  Direct Link  |  

  25. Aribas, A., M. Kayrak, S. Ulucan, A. Keser and K. Demir et al., 2014. The relationship between uric acid and erectile dysfunction in hypertensive subjects. Blood Pressure, 23: 370-376.
    CrossRef  |  Direct Link  |  

  26. Akin, F., B. Ayca, N. Kose, O. Celik and Y. Yilmaz et al., 2014. Serum vitamin D and c-reactive protein levels are independently associated with diastolic dysfunction. J. Invest. Med., 62: 43-48.
    CrossRef  |  Direct Link  |  

  27. Afsar, B., M. Takir, O. Kostek, A. Covic and M. Kanbay, 2014. Endocan: A new molecule playing a role in the development of hypertension and chronic kidney disease? J. Clin. Hypertens., 16: 914-916.
    CrossRef  |  Direct Link  |  

  28. Afsar, B., A. Covic and M. Kanbay, 2014. Renal artery stenting in patients with uncontrolled hypertension: Should we? And to whom? J. Clin. Hypertens., 16: 479-481.
    CrossRef  |  Direct Link  |  

  29. Yilmaz, M.I., F. Turgut, M. Kanbay, M. Saglam and A. Sonmez et al., 2013. Serum gamma-glutamyltransferase levels are inversely related to endothelial function in chronic kidney disease. Int. Urol. Nephrol., 45: 1071-1078.
    CrossRef  |  Direct Link  |  

  30. Turkmen, K., H.Z. Tonbul, F.M. Erdur, I. Guney and H. Kayikcioglu et al., 2013. Peri-aortic fat tissue and malnutrition-inflammation-atherosclerosis/calcification syndrome in end-stage renal disease patients. Int. Urol. Nephrol., 45: 857-867.
    CrossRef  |  Direct Link  |  

  31. Turak, O., F. Ozcan, D. Tok, A. Isleyen and E. Sokmen et al., 2013. Serum uric acid, inflammation and nondipping circadian pattern in essential hypertension. J. Clin. Hypertens., 15: 7-13.
    CrossRef  |  Direct Link  |  

  32. Solak, Y., M.I. Yilmaz, M. Saglam, S. Demirbas and S. Verim et al., 2013. Mean corpuscular volume is associated with endothelial dysfunction and predicts composite cardiovascular events in patients with chronic kidney disease. Nephrology, 18: 728-735.
    CrossRef  |  Direct Link  |  

  33. Sen, N., B. Afsar, F. Ozcan, E. Buyukkaya and A. Isleyen et al., 2013. The neutrophil to lymphocyte ratio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Atherosclerosis, 228: 203-210.
    CrossRef  |  Direct Link  |  

  34. Kanbay, M., Y. Bayram, Y. Solak and P.W. Sanders, 2013. Dietary potassium: A key mediator of the cardiovascular response to dietary sodium chloride. J. Am. Soc. Hypertens., 7: 395-400.
    CrossRef  |  Direct Link  |  

  35. Kanbay, M., O. Turak and R.J. Johnson, 2013. REPLY TO: Serum uric acid still carries controversies about its role in endothelial dysfunction. J. Clin. Hypertens., 15: 297-297.
    CrossRef  |  Direct Link  |  

  36. Kanbay, M., M.I. Yilmaz, B. Afsar, M. Saglam and E.O. Akgul et al., 2013. Serum calcitonin and endothelial dysfunction in chronic kidney disease: A novel risk factor? Int. Urol. Nephrol., 45: 151-156.
    CrossRef  |  Direct Link  |  

  37. Kanbay, M., M. Segal, B. Afsar, D.H. Kang, B. Rodriguez-Iturbe and R.J. Johnson, 2013. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart, 99: 759-766.

  38. Johnson, R.J., L.G. Sanchez-Lozada, M. Mazzali, D.I. Feig, M. Kanbay and Y.Y. Sautin, 2013. What are the key arguments against uric acid as a true risk factor for hypertension? Hypertension, 61: 948-951.
    CrossRef  |  Direct Link  |  

  39. Solak, Y., Z. Biyik, H. Atalay, A. Gaipov and F. Guney et al., 2012. Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: A prospective, crossover study. Nephrology, 17: 710-717.
    CrossRef  |  Direct Link  |  

  40. Solak, Y., E.E. Gul, M. Kayrak, H. Atalay and T. Abdulhalikov et al., 2012. Electrocardiographic P-wave characteristics in patients with end-stage renal disease: P-index and interatrial block. Int. Urol. Nephrol., 45: 511-517.
    CrossRef  |  Direct Link  |  

  41. Ozkok, A., O.C. Elcioglu, T. Cukadar, A. Bakan and G. Sasak et al., 2012. Low serum pancreatic enzyme levels predict mortality and are associated with malnutrition-inflammation-atherosclerosis syndrome in patients with chronic kidney disease. Int. Urol. Nephrol., 45: 477-484.
    CrossRef  |  Direct Link  |  

  42. Lanaspa, M.A., L.G. Sanchez-Lozada, Y.J. Choi, C. Cicerchi and M. Kanbay et al., 2012. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: Potential role in fructose-dependent and-independent fatty liver. J. Biol. Chem., 287: 40732-40744.
    CrossRef  |  Direct Link  |  

  43. Kanbay, M., M.I. Yilmaz, M. Apetrii, M. Saglam and H. Yaman et al., 2012. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients. Am. J. Nephrol., 36: 228-237.
    CrossRef  |  Direct Link  |  

  44. Kanbay, M., M.I. Yilmaz, A. Sonmez, Y. Solak and M. Saglam et al., 2012. Serum uric acid independently predicts cardiovascular events in advanced nephropathy. Am. J. Nephrol., 36: 324-331.
    CrossRef  |  Direct Link  |  

  45. Kanbay, M., M. Wolf, Y. Selcoki, Y. Solak and M. Ikizek et al., 2012. Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease. Int. Urol. Nephrol., 44: 1169-1175.
    CrossRef  |  Direct Link  |  

  46. Kanbay, M., K. Turkmen, T. Ecder and A. Covic, 2012. Ambulatory blood pressure monitoring: From old concepts to novel insights. Int. Urol. Nephrol., 44: 173-182.
    CrossRef  |  Direct Link  |  

  47. Akin, F., B. Ayca, N. Kose, M. Duran and M. Sar et al., 2012. Serum vitamin D levels are independently associated with severity of coronary artery disease. J. Invest. Med., 60: 869-873.
    CrossRef  |  Direct Link  |  

  48. Akcay, A.B., M.F. Ozlu, N. Sen, S. Cay and O.H. Ozturk et al., 2012. Prognostic significance of neutrophil gelatinase-associated lipocalin in ST-segment elevation myocardial infarction. J. Invset. Med., 60: 508-513.
    CrossRef  |  PubMed  |  Direct Link  |  

  49. Afsar, B., R. Elsurer and M. Kanbay, 2012. The relationship between breakfast, lunch and dinner eating pattern and hemodialysis sessions, quality of life, depression and appetite in hemodialysis patients. Int. Urol. Nephrol., 44: 1507-1514.
    CrossRef  |  Direct Link  |  

  50. Yilmaz, M.I., Y. Solak, A. Covic, D. Goldsmith and M. Kanbay, 2011. Renal anemia of inflammation: The name is self-explanatory. Blood Purif., 32: 220-225.
    CrossRef  |  Direct Link  |  

  51. Sen, N., M.F. Ozlu, E.O. Akgul, S. Kanat and T. Cayci et al., 2011. Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion. Atherosclerosis, 219: 304-310.
    CrossRef  |  Direct Link  |  

  52. Ozturk, M.A., M. Kanbay, B. Kasapoglu, A.M. Onat, G. Guz, D.E. Furst and E. Ben-Chetrit, 2011. Therapeutic approach to familial Mediterranean fever: A review update. Clin. Exp. Rheumatol., 29: S77-S86.
    Direct Link  |  

  53. Karadag, R., U.C. Keskin, A. Koktener, Y. Selcoki, I.F. Hepsen and M. Kanbay, 2011. Ocular pulse amplitude and retrobulbar blood flow change in dipper and non-dipper individuals. Eye, 25: 762-766.
    CrossRef  |  Direct Link  |  

  54. Kanbay, M., Y. Solak, A. Covic and D. Goldsmith, 2011. Sudden cardiac death in patients with chronic kidney disease: Prevention is the sine qua non. Kidney Blood Pres. Res., 34: 269-276.
    CrossRef  |  Direct Link  |  

  55. Kanbay, M., Y. Chen, Y. Solak and P.W. Sanders, 2011. Mechanisms and consequences of salt sensitivity and dietary salt intake. Curr. Opin. Nephrol. Hyp., 20: 37-43.
    CrossRef  |  Direct Link  |  

  56. Kanbay, M., M.I. Yilmaz, A. Sonmez, F. Turgut and M. Saglam et al., 2011. Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease. Am. J. Nephrol., 33: 298-304.
    CrossRef  |  Direct Link  |  

  57. Kanbay, M., M. Ikizek, Y. Solak, Y. Selcoki and S. Uysal et al., 2011. Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease. Am. J. Nephrol., 33: 325-331.
    CrossRef  |  Direct Link  |  

  58. Kanbay, M., B. Huddam, A. Azak, Y. Solak and G.K. Kadioglu et al., 2011. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin. J. Am. Soc. Nephrol., 6: 1887-1894.

  59. Kanbay, M., B. Afsar and A. Covic, 2011. Uric acid as a cardiometabolic risk factor: To be or not to be. Contrib. Nephrol., 171: 62-67.
    CrossRef  |  Direct Link  |  

  60. Johnson, R.J., M. Kanbay, D.H. Kang, L.G. Sanchez-Lozada and D. Feig, 2011. Uric acid a clinically useful marker to distinguish preeclampsia from gestational hypertension. Hypertension, 58: 548-549.
    Direct Link  |  

  61. Johnson, R.J., M. Kanbay and L.G. Sanchez-Lozada, 2011. The rediscovery of uric acid in cardiorenal disease: Introduction. Semin. Nephrol., 31: 391-393.

  62. Duranay, M., L. Segall, N. Sen, F.M. Yilmaz and M. Cetin et al., 2011. Bone morphogenic protein-7 serum level decreases significantly in patients with contrast-induced nephropathy. Int. Urol. Nephrol., 43: 807-812.
    CrossRef  |  Direct Link  |  

  63. Basar, N., N. Sen, S. Kanat, M.F. Ozlu and F. Ozcan et al., 2011. Lower fetuin-A predicts angiographic impaired reperfusion and mortality in ST-elevation myocardial infarction. J. Investig. Med., 59: 816-822.
    CrossRef  |  Direct Link  |  

  64. Basar, N., N. Sen, F. Ozcan, G. Erden and S. Kanat et al., 2011. Elevated serum uric acid predicts angiographic impaired reperfusion and 1-year mortality in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention. J. Investig. Med., 59: 931-937.
    CrossRef  |  Direct Link  |  

  65. Afsar, B., R. Elsurer, A. Covic, R.J. Johnson and M. Kanbay, 2011. Relationship between uric acid and subtle cognitive dysfunction in chronic kidney disease. Am. J. Nephrol., 34: 49-54.
    CrossRef  |  Direct Link  |  

  66. Mazzali, M., M. Kanbay, M.S. Segal, M. Shafiu, D. Jalal, D.I. Feig and R.J. Johnson, 2010. Uric acid and hypertension: Cause or effect? Curr. Rheumatol. Rep., 12: 108-117.
    CrossRef  |  Direct Link  |  

  67. Kargili, A., F.H. Turgut, F. Karakurt, B. Kasapoglu, M. Kanbay and A. Akcay, 2010. A forgotten but important risk factor for severe hyponatremia: Myxedema coma. Clinics, 65: 447-448.
    CrossRef  |  Direct Link  |  

  68. Kanbay, M., Y. Solak, E. Dogan, M.A. Lanaspa and A. Covic, 2010. Uric acid in hypertension and renal disease: The chicken or the egg? Blood Purif., 30: 288-295.
    CrossRef  |  Direct Link  |  

  69. Kanbay, M., M.A. Perazella, B. Kasapoglu, M. Koroglu and A. Covic, 2010. Erythropoiesis stimulatory agent- resistant anemia in dialysis patients: Review of causes and management. Blood Purif., 29: 1-12.
    CrossRef  |  Direct Link  |  

  70. Kanbay, M., M. Nicoleta, Y. Selcoki, M. Ikizek and M. Aydin et al., 2010. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease. Clin. J. Am. Soc. Nephrol., 5: 1780-1786.
    CrossRef  |  Direct Link  |  

  71. Kanbay, M., L.G. Sanchez-Lozada, M. Franco, M. Madero and Y. Solak et al., 2010. Microvascular disease and its role in the brain and cardiovascular system: A potential role for uric acid as a cardiorenal toxin. Nephrol. Dial. Transplant., 26: 430-437.
    CrossRef  |  Direct Link  |  

  72. Kanbay, M., D. Goldsmith, M.E. Uyar, F. Turgut and A. Covic, 2010. Magnesium in chronic kidney disease: Challenges and opportunities. Blood Purif., 29: 280-292.
    CrossRef  |  Direct Link  |  

  73. Kanbay, M., B. Kasapoglu and M.A. Perazella, 2010. Acute tubular necrosis and pre-renal acute kidney injury: Utility of urine microscopy in their evaluation-a systematic review. Int. Urol. Nephrol., 42: 425-433.
    CrossRef  |  Direct Link  |  

  74. Kanbay, M., B. Afsar, P. Gusbeth-Tatomir and A. Covic, 2010. Arterial stiffness in dialysis patients: Where are we now? Int. Urol. Nephrol., 42: 741-752.
    CrossRef  |  Direct Link  |  

  75. Kanbay, M., B. Afsar, D. Goldsmith and A. Covic, 2010. Sudden death in hemodialysis: An update. Blood Purif., 30: 135-145.
    CrossRef  |  Direct Link  |  

  76. Duranay, M., M. Kanbay, H. Akay, S. Unverdi and H. Surer et al., 2010. Nebivolol improves renal function in patients who underwent angioplasty due to renal artery stenosis: A pilot study. Nephron Clin. Pract., 114: c213-c217.
    CrossRef  |  Direct Link  |  

  77. Covic, A., M. Kanbay, L. Voroneanu, F. Turgut, D.N. Serban, I.L. Serban and D.J. Goldsmith, 2010. Vascular calcification in chronic kidney disease. Clin. Sci., 119: 111-121.

  78. Bavbek, N., H. Akay, B. Uz, E. Uz and F. Turgut et al., 2010. The effects of L-carnitine therapy on respiratory function tests in chronic hemodialysis patients. Renal Fail., 32: 157-161.
    CrossRef  |  Direct Link  |  

  79. Turgut, F., B. Kasapoglu and M. Kanbay, 2009. Uric acid, cardiovascular mortality and long-term outcomes in CKD. Am. J. Kidney Dis., 54: 582-582.

  80. Karadag, R., R. Yagci, B. Aydin, M. Kanbay and M. Erdurmus et al., 2009. Effects of erytropoietin treatment and hemodialysis on the serum endothelin level and intraocular pressure of hemodialysis patients. Int. Ophthalmol., 29: 385-388.
    CrossRef  |  Direct Link  |  

  81. Kanbay, M., F. Turgut, A. Covic and D. Goldsmith, 2009. Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: A review of the evidence. J. Nephrol., 22: 598-609.

  82. Kanbay, M., D. Goldsmith, A. Akcay and A. Covic, 2009. Phosphate: The silent stealthy cardiorenal culprit in all stages of chronic kidney disease. Blood Purif., 27: 220-230.
    CrossRef  |  Direct Link  |  

  83. Kanbay, M., A. Covic, S.G. Coca, F. Turgut, A. Akcay and C.R. Parikh, 2009. Sodium bicarbonate for the prevention of contrast-induced nephropathy: A meta-analysis of 17 randomized trials. Int. Urol. Nephrol., 41: 617-627.
    CrossRef  |  Direct Link  |  

  84. Guz, G., M. Kanbay and M.A. Ozturk, 2009. Current perspectives on familial mediterranean fever. Curr. Opin. Infect. Dis., 22: 309-315.
    CrossRef  |  Direct Link  |  

  85. Uz, E., O. BayraK, E. Uz, A. Kaya and R. Bayrak et al., 2008. Nigella sativa oil for prevention of chronic cyclosporine nephrotoxicity: An experimental model. Am. J. Nephrol., 28: 517-522.
    CrossRef  |  Direct Link  |  

  86. Turkay, C., O. Yonem, S. Arici, A. Koyuncu and M. Kanbay, 2008. Effect of angiotensin-converting enzyme inhibition on experimental hepatic fibrogenesis. Digest. Dis. Sci., 53: 789-793.
    CrossRef  |  Direct Link  |  

  87. Turgut, F., O. Bayrak, M. Kanbay, A. Ozkara and E. Uz et al., 2008. Circadian rhythm of blood pressure in patients with benign prostatic hyperplasia. Scandinavian J. Urol. Nephrol., 42: 47-52.
    CrossRef  |  Direct Link  |  

  88. Turgut, F., M. Kanbay, M.R. Metin, E. Uz, A. Akcay and A. Covic, 2008. Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int. Urol. Nephrol., 40: 1075-1082.
    CrossRef  |  

  89. Selcoki, Y., C. Gorpelioglu, F. Turgut, E. Sarifakioglu and A. Ozkara et al., 2008. Isotretinoin: Is there any arrhythmic effect? Int. J. Dermatol., 47: 195-197.
    CrossRef  |  Direct Link  |  

  90. Schmitt, R., S. Coca, M. Kanbay, M.E. Tinetti, L.G. Cantley and C.R. Parikh, 2008. Recovery of kidney function after acute kidney injury in the elderly: A systematic review and meta-analysis. Am. J. Kidney Dis., 52: 262-271.
    CrossRef  |  Direct Link  |  

  91. Perazella, M.A., S.G. Coca, M. Kanbay, U.C. Brewster and C.R. Parikh, 2008. Diagnostic value of urine microscopy for differential diagnosis of acute kidney injury in hospitalized patients. Clin. J. Am. Soc. Nephrol., 3: 1615-1619.
    PubMed  |  

  92. Kurtaran, H., M.E. Uyar, B. Kasapoglu, C. Turkay, T. Yilmaz, A. Akcay and M. Kanbay, 2008. Role of helicobacter pylori in pathogenesis of upper respiratory system diseases. J. Natl. Med. Assoc., 100: 1224-1230.
    Direct Link  |  

  93. Kanbay, M., F. Turgut, M.E. Uyar, A. Akcay and A. Covic, 2008. Causes and mechanisms of nondipping hypertension. Clin. Exp. Hyp., 30: 585-597.
    CrossRef  |  Direct Link  |  

  94. Kanbay, M., B. Kasapoglu, F. Turgut and A. Akcay, 2008. Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int., 74: 967-968.
    CrossRef  |  Direct Link  |  

  95. Ellis, M.J., C.R. Parikh, J.K. Inrig, M. Kambay and U.D. Patel, 2008. Chronic kidney disease after hematopoietic cell transplantation: A systematic review. Am. J. Transplant., 8: 2378-2390.
    CrossRef  |  Direct Link  |  

  96. Bavbek, N., B. Isik, A. Kargili, E. Uz and B. Uz et al., 2008. Association of obesity with inflammation in occult chronic kidney disease. J. Nephrol., 21: 761-767.
    Direct Link  |  

  97. Altay, M., F. Turgut, H. Akay, M. Kanbay and A. Babali et al., 2008. Dyspepsia in Turkish patients on continuous ambulatory peritoneal dialysis. Int. Urol. Nephrol., 40: 211-217.
    CrossRef  |  Direct Link  |  

  98. Yanik, B., N. Bavbek, T. Yanik, I. Inegol and M. Kanbay et al., 2007. The effect of alendronate, risedronate and raloxifene on renal functions, based on the Cockcroft and Gault method, in postmenopausal women. Renal Failure, 29: 471-476.
    CrossRef  |  Direct Link  |  

  99. Uz, E., N. Bavbek, F.H. Turgut, M. Kanbay, A. Kaya and A. Akcay, 2007. Cefuroxime-induced lupus. J. Nat. Med. Assoc., 99: 1066-1067.
    Direct Link  |  

  100. Usta, B., M. Gozdemir, F. Turgut, H. Sert, M. Kanbay, R.I. Demircioglu and A. Akcay, 2007. Does hypocalcemia trigger pulmonary embolism? Med. Hypotheses., 68: 464-465.

  101. Turgut, F., M. Kanbay, B. Uz, A. Carlioglu and Y. Selcoki et al., 2007. A forgotten but important risk factor for infective endocarditis in patients with prosthetic valve: Pedicure. Scand. J. Infect. Dis., 39: 274-276.
    CrossRef  |  Direct Link  |  

  102. Turgut, F., M. Kanbay, B. Isik and A. Akcay, 2007. Risk factors affecting the incidence of chronic kidney disease. Kidney Int., Vol. 71. 10.1038/sj.ki.5002245.
    CrossRef  |  Direct Link  |  

  103. Turgut, F., M. Kanbay, A. Kaya, B. Uz and A. Akcay, 2007. Bilateral renal artery embolization in a case with severe proteinuria secondary to amyloidosis in a hemodialysis patient. Amyloid, 14: 157-158.
    CrossRef  |  Direct Link  |  

  104. Selcuk, H., M. Korkmaz, M. Kanbay, E. Tore and H. Sumer et al., 2007. Total colonic polyp diameter: A marker for the risk of malignancy? Hepato-gastroenterology, 55: 936-939.
    Direct Link  |  

  105. Selcuk, H., I. Uruc, M.A. Temel, S. Ocal and B. Huddam et al., 2007. Factors prognostic of survival in patients awaiting liver transplantation for end-stage liver disease. Digest. Dis. Sci., 52: 3217-3223.
    CrossRef  |  Direct Link  |  

  106. Ozkara, A., F. Turgut, Y. Selcoki, A. Karanfil and M.R. Metin et al., 2007. Probrain natriuretic peptide for assessment of efficacy in heart failure treatment. Adv. Ther., 24: 1233-1239.
    CrossRef  |  Direct Link  |  

  107. Kanbay, M., N. Bavbek, T. Delibasi, C. Koca and A. Kaya et al., 2007. Effect of peritoneal dialysis solution type on serum lipid levels in end-stage renal disease. Renal Failure, 29: 309-313.
    CrossRef  |  Direct Link  |  

  108. Kanbay, M., M. Alkis, F. Turgut, E. Uz, N. Bavbek and A. Akcay, 2007. Hyponatremia due to an additive effect of carbamazepine and clarithromycin. S. Med. J., Vol. 100. 10.1097/SMJ.0b013e31802ef45f.
    CrossRef  |  PubMed  |  Direct Link  |  

  109. Kanbay, M., F. Turgut, F. Karakurt, B. Isik and R. Alkan et al., 2007. Relation between serum thyroid hormone and ‘nondipper'circadian blood pressure variability. Kidney Blood Pressure Res., 30: 416-420.
    CrossRef  |  Direct Link  |  

  110. Kanbay, M., B. Kasapoglu, F. Turgut, E. Uz, N. Bavbek and A. Akcay, 2007. Helicobacter pylori: A major risk factor for endothelial dysfunction? Med. Hypotheses. 69: 227-228.
    CrossRef  |  PubMed  |  Direct Link  |  

  111. Kanbay, M., B. Kasapoglu, B. Isik, F. Turgut, E. Uz, N. Bavbek and A. Akcay, 2007. H. pylori: A major risk factor for 'non-dipper' circadian variability profile in blood pressure? Med. Hypotheses, 69: 463-464.
    CrossRef  |  PubMed  |  Direct Link  |  

  112. Kanbay, M., B. Kasapoglu and A. Akcay, 2007. An occult risk factor for proteinuria: Helicobacter pylori infection. Med. Hypotheses, 69: 709-710.
    CrossRef  |  Direct Link  |  

  113. Kanbay, M., B. Isik, A. Akcay, A. Ozkara and F. Karakurt et al., 2007. Relation between serum calcium, phosphate, parathyroid hormone and 'nondipper' circadian blood pressure variability profile in patients with normal renal function. Am. J. Nephrol., 27: 516-521.
    CrossRef  |  Direct Link  |  

  114. Kanbay, M., A. Ozkara, Y. Selcoki, B. Isik and F. Turgut et al., 2007. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence and proteinuria in patients with normal renal functions. Int. Urol. Nephrol., 39: 1227-1233.
    CrossRef  |  Direct Link  |  

  115. Kanbay, M., A. Kanbay and S. Boyacioglu, 2007. Helicobacter pylori infection as a possible risk factor for respiratory system disease: A review of the literature. Respir. Med., 101: 203-209.
    CrossRef  |  Direct Link  |  

  116. Kanbay, M., A. Akcay, T. Delibasi, B. Uz and A. Kaya et al., 2007. Comparison of effects of darbepoetin alfa and epoetin alfa on serum endothelin level and blood pressure. Adv. Ther., 24: 346-352.
    CrossRef  |  Direct Link  |  

  117. Duranay, M., M. Kanbay, F. Turgut, M. Altay and A. Akcay, 2007. Comparison of incidence of peritonitis between peritoneal dialysis solution types. Nephron Clin. Pract., 106: c57-c60.
    CrossRef  |  Direct Link  |  

  118. Aytac, S., C. Turkay and M. Kanbay, 2007. Helicobacter pylori stool antigen assay in hyperemesis gravidarum: A risk factor for hyperemesis gravidarum or not? Digestive Dis. Sci., 52: 2840-2843.
    CrossRef  |  PubMed  |  Direct Link  |  

  119. Selcuk, H., M. Kanbay, M. Korkmaz, P. Gulsener, G. Gur, U. Yilmaz and S. Boyacioglu, 2006. Route of nutrition has no effect on the development of infectious complications. J. Nat. Med. Assoc., 98: 1963-1966.
    Direct Link  |  

  120. Selcuk, H., M. Kanbay, M. Korkmaz, G. Gur and A. Akcay et al., 2006. Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment. Dig. Dis. Sci., 51: 1420-1425.
    CrossRef  |  Direct Link  |  

  121. Selcuk, H., M. Kanbay, K. Murat and U. Yilmaz, 2006. Liver dysfunction after a gluten-free diet in a patient with celiac disease: A new link? Dig. Dis. Sci., 51: 213-214.
    CrossRef  |  Direct Link  |  

  122. Sahin, M., N.B. Tutuncu, M. Kanbay and N.D. Guvener, 2006. Surgery for hyperthyroidism in down syndrome: Case report. Mount Sinai J. Med., 73: 784-786.
    PubMed  |  

  123. Kaya, A., M. Kanbay, O. Bayrak, H. Kurtaran, N. Ark, F. Catal and A. Akcay, 2006. Concomitant nephrotic syndrome with antinuclear antibody seropositivity and Hashimoto thyroiditis in a patient with mycosis fungoides. South Med. J., 99: 631-631.
    CrossRef  |  Direct Link  |  

  124. Kaya, A., M. Kanbay, O. Bayrak, G. Eken, L. Memis, A. Akcay and M. Duranay, 2006. Primary renal lymphoma associated with hepatitis C virus infection. Leuk Lymphoma, 47: 1976-1978.
    PubMed  |  

  125. Kanbay, M., T. Delibasi, A. Kaya, T. Aydogan and C. Koca et al., 2006. Effect of dialysis type on serum lipids, apolipoproteins and lipoproteins. Renal Failure, 28: 567-571.
    CrossRef  |  Direct Link  |  

  126. Kanbay, M., T. Aydogan, R. Bozalan, A. Isik, B. Uz, A. Kaya and A. Akcay, 2006. A rare but serious side effect of levofloxacin hypoglycemia in a geriatric patient. Diabet. Care, 29: 1716-1717.
    CrossRef  |  Direct Link  |  

  127. Kanbay, M., K. Altundag, G. Gur and S. Boyacioglu, 2006. Non-Hodgkin's lymphoma presenting with granulomatous hepatitis and hemophagocytosis. Leuk. Lymphoma, 47: 767-769.
    PubMed  |  

  128. Kanbay, M., H. Selcuk, U. Yilmaz and S. Boyacioglu, 2006. Recurrent acute pancreatitis probably secondary to lisinopril. S. Med. J., 99: 1388-1389.
    Direct Link  |  

  129. Kanbay, M., H. Selcuk, G. Gur, U. Yilmaz and S. Boyacioglu, 2006. Involvement of the esophagus in a patient with pemphigus vulgaris who was on immunosuppressive therapy. J. Natl. Med. Assoc., 98: 1369-1370.
    Direct Link  |  

  130. Kanbay, M., H. Selcuk, G. Gur, N. Dagli, S. Karakus and U. Yilmaz, 2006. Response to peginterferon treatment in hepatitis C virus-associated splenic lymphoma with villous lymphocytes. Am. J. Hematol., 81: 304-305.
    CrossRef  |  Direct Link  |  

  131. Kanbay, M., H. Selcuk and U. Yilmaz, 2006. Dysphagia caused by cervical osteophytes: A rare case. J. Am. Geriatr. Soc., 54: 1147-1148.
    CrossRef  |  Direct Link  |  

  132. Kanbay, M., G. Gur, A. Akcay, H. Selcuk and U. Yilmaz et al., 2006. Is hepatitis C virus positivity a contributing factor to occult hepatitis B virus infection in hemodialysis patients? Dig. Dis. Sci., 51: 1962-1966.
    CrossRef  |  Direct Link  |  

  133. Kanbay, M., A. Yildirir, T. Ulus, M. Bilgi, A. Kucuk and H. Muderrisoglu, 2006. Rhesus positivity and low high-density lipoprotein cholesterol: A new link? Asian Cardiovasc. Thorac. Ann., 14: 119-122.
    CrossRef  |  Direct Link  |  

  134. Kanbay, M., A. Yildirir, A. Akcay, T. Colak, F.N. Ozdemir, H. Muderrisoglu and M. Haberal, 2006. Effects of immunosuppressive drugs on serum lipid levels in renal transplant recipients. Transplant. Proc., 38: 502-505.
    CrossRef  |  Direct Link  |  

  135. Kanbay, M., A. Kaya, R. Bozalan, T. Aydogan, B. Uz, A. Isik and A. Akcay, 2006. Gabapentin induced edema in a geriatric patient. Clin. Neuropharmacol., 29: 186-186.
    CrossRef  |  Direct Link  |  

  136. Guler, Z.M., A. Kanbay, M. Kanbay, B. Ciftci and Y. Erdogan, 2006. Tuberculous epididymitis presenting with Addison's disease: A rare case. J. Natl. Med. Assoc., 98: 1175-1176.
    Direct Link  |  

  137. Aydogan, T., M. Kanbay, O. Alici and A. Kosar, 2006. Incidence and etiology of thrombocytosis in an adult Turkish population. Platelets, 17: 328-331.
    CrossRef  |  Direct Link  |  

  138. Aydogan, T., M. Kanbay, B. Uz, A. Kaya and A. Isik et al., 2006. Fatal hyperphosphatemia secondary to a phosphosoda bowel preparation in a geriatric patient with normal renal function. J. Clin. Gastroenterol., 40: 177-177.
    Direct Link  |  

  139. Altay, M., M. Kanbay, I. Kurultak, F.A. Altay, T. Aydogan, A. Akcay and M. Duranay, 2006. A case of bilateral psoas abscesses and lumbar osteomyelitis due to recurrent salmonella infection. J. Natl. Med. Assoc., 98: 1855-1856.
    Direct Link  |  

  140. Yildirim, E., M. Kanbay, O. Ozbek, M. Coskun and S. Boyacioglu, 2005. Isolated idiopathic ovarian vein thrombosis: A rare case. Int. Urogynecol. J. Pelvic. Floor Dysfunct., 16: 308-310.
    CrossRef  |  Direct Link  |  

  141. Kanbay, M., S. Karakus and U. Yilmaz, 2005. Portal vein thrombosis due to hyperhomocysteinemia caused by vitamin B-12 deficiency. Dig. Dis. Sci., 50: 2362-2363.
    CrossRef  |  Direct Link  |  

  142. Kanbay, M., H. Sekuk, U. Yilmaz, G. Gur and S. Boyacıoglu, 2005. Acute pancreatitis associated with combined lisinopril and atorvastatin therapy. Dig. Dis., 23: 92-94.
    CrossRef  |  PubMed  |  Direct Link  |  

  143. Kanbay, M., G. Gur, S. Akcay and U. Yilmaz, 2005. Helicobacter pylori seroprevalence in patients with chronic bronchitis. Respir. Med., 99: 1213-1216.
    CrossRef  |  Direct Link  |  

  144. Kanbay, M., G. Gur, M. Yucel, U. Yilmaz and S. Boyacioglu, 2005. Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Dig. Dis. Sci., 50: 1228-1231.
    CrossRef  |  Direct Link  |  

  145. Kanbay, M., G. Gur, M. Yucel, U. Yilmaz and H. Muderrisoglu, 2005. Helicobacter pylori seroprevalence in patients with coronary artery disease. Dig. Dis. Sci., 50: 2071-2074.
    CrossRef  |  Direct Link  |  

  146. Kanbay, M., G. Gur, H. Arslan, U. Yilmaz and S. Boyacioglu, 2005. The relationship of ABO blood group, age, gender, smoking and Helicobacter pylori infection. Dig. Dis. Sci., 50: 1214-1217.
    CrossRef  |  Direct Link  |  

  147. Kanbay, M., A. Yildirir, H. Bozbas, T. Ulus and M. Bilgi et al., 2005. Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients. Renal Failure, 27: 297-303.
    CrossRef  |  Direct Link  |  

  148. Kanbay, M., A. Sengul and N. Guvener, 2005. Trauma induced thyroid storm complicated by multiple organ failure. Chin. Med. J. Beıjıng English Edition, 118: 963-965.

  149. Kanbay, M., A. Akcay, B. Huddam, C.A. Usluogullari, Z. Arat, F.N. Ozdemir and M. Haberal, 2005. Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients. Transplant. Proc., 37: 3119-3120.
    CrossRef  |  Direct Link  |  

  150. Guler, Z.M., A. Kanbay, B. Ciftci, M. Kanbay, A. Yilmaz, Y. Agackiran and Y. Erdogan, 2005. Kaposi sarcoma secondary to pulmonary tuberculosis: A rare case. South Med. J., 98: 933-934.
    PubMed  |  

  151. Karakus, S., M. Kanbay, H.K. Koseoglu, T. Colak and M. Haberal, 2004. Causes of anemia in renal transplant recipients. Transplant. Proc., 36: 164-165.
    CrossRef  |  Direct Link  |  

  152. Kanbay, M., M. Korkmaz, U. Yilmaz, G. Gur and S. Boyacıoglu, 2004. Acute pancreatitis due to ramipril therapy. Postgrad. Med. J., 80: 617-618.
    CrossRef  |  Direct Link  |  

  153. Kanbay, M., G. Gur, M. Korkmaz, B. Demirci and S. Boyacioglu, 2004. Hepatic lymphoma metastasis presenting with severe acute liver failure: A rare case. Turk. J. Gastroenterol., 15: 94-96.
    Direct Link  |  

  154. Kanbay, M., G. Gur, F. Boyvat, A. Tasdelen and S. Boyacioglu, 2004. Spontaneous aortocaval fistula presenting with acute liver and renal failure: A case report. Turk. J. Gastroenterol., 15: 169-172.
    Direct Link  |  

  155. Akcay, A., M. Kanbay, S. Sezer and F.N. Ozdemir, 2004. Acute renal failure and hepatotoxicity associated with roxithromycin. Ann. Pharmacother., 38: 721-722.
    CrossRef  |  Direct Link  |  

  156. Akcay, A., M. Kanbay, E. Agca, S. Sezer and F.N. Ozdemir, 2004. Neutropenia due to clopidogrel in a patient with end-stage renal disease. Ann. Pharmacother., 38: 1538-1539.
    CrossRef  |  Direct Link  |  
Member since March, 2016